Watch Ticker

Athira Pharma, Inc. Common Stock

Go to Athira Pharma, Inc. Common Stock Website

$0.37

0.00 (-0.03%)

Live

Previous Close

$0.3725

Day Range

$0 - $0

Previous Day Range

$0.3646 - $0.3899

Market Cap

$14.5 million USD

Day Vol.

Previous Day Vol.

71454

Currency

USD

Primary Exchange

Nasdaq

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit

Athira Pharma announced positive results from a Phase 1 clinical trial of its drug candidate ATH-1105 in healthy volunteers, supporting continued development for the potential treatment of amyotrophic lateral sclerosis (ALS). The company plans to initiate a clinical trial in ALS patients in late 2025.

Related tickers: ATHA.

Read Full Article

N/A - Athira (ATHA) Completes Dosing in Alzheimer's Study, Stock Up - Zacks Investment Research

Athira Pharma has dosed the last patient in the phase II/III LIFT-AD study evaluating its pipeline candidate, fosgonimeton, for the treatment of mild-to-moderate Alzheimer's disease. The study is designed to assess the treatment effects of fosgonimeton across multiple aspects of the disease.

Related tickers: ATHA, ACRV, ADPT, RAPT.

Read Full Article

Trending Tickers

Please sign in to view